Philippe MARCHETTI
Philippe MARCHETTI
INSERM CHRU Université Lille
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
N Zamzami, P Marchetti, M Castedo, D Decaudin, A Macho, T Hirsch, ...
The Journal of experimental medicine 182 (2), 367-377, 1995
17751995
Mitochondrial control of nuclear apoptosis.
N Zamzami, SA Susin, P Marchetti, T Hirsch, I Gómez-Monterrey, ...
The Journal of experimental medicine 183 (4), 1533-1544, 1996
17401996
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.
SA Susin, N Zamzami, M Castedo, T Hirsch, P Marchetti, A Macho, ...
The Journal of experimental medicine 184 (4), 1331-1341, 1996
14831996
Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.
N Zamzami, P Marchetti, M Castedo, C Zanin, JL Vayssiere, PX Petit, ...
The Journal of experimental medicine 181 (5), 1661-1672, 1995
14261995
Mitochondrial permeability transition is a central coordinating event of apoptosis.
P Marchetti, M Castedo, SA Susin, N Zamzami, T Hirsch, A Macho, ...
The Journal of experimental medicine 184 (3), 1155-1160, 1996
10461996
The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
T Hirsch, P Marchetti, SA Susin, B Dallaporta, N Zamzami, I Marzo, ...
Oncogene 15 (13), 1573-1581, 1997
6241997
Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis
N Zamzami, P Marchetti, M Castedo, T Hirsch, SA Susin, B Masse, ...
FEBS letters 384 (1), 53-57, 1996
5301996
Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis.
M Castedo, T Hirsch, SA Susin, N Zamzami, P Marchetti, A Macho, ...
The Journal of Immunology 157 (2), 512-521, 1996
4381996
Study of mitochondrial membrane potential, reactive oxygen species, DNA fragmentation and cell viability by flow cytometry in human sperm
C Marchetti, G Obert, A Deffosez, P Formstecher, P Marchetti
Human Reproduction 17 (5), 1257-1265, 2002
4132002
Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
D Decaudin, S Geley, T Hirsch, M Castedo, P Marchetti, A Macho, ...
Cancer Research 57 (1), 62-67, 1997
4041997
Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis.
A Macho, T Hirsch, I Marzo, P Marchetti, B Dallaporta, SA Susin, ...
The Journal of Immunology 158 (10), 4612-4619, 1997
3881997
Targeting chelatable iron as a therapeutic modality in Parkinson's disease
D Devos, C Moreau, JC Devedjian, J Kluza, M Petrault, C Laloux, ...
Antioxidants & redox signaling 21 (2), 195-210, 2014
3732014
Mitochondrial permeability transition triggers lymphocyte apoptosis.
P Marchetti, T Hirsch, N Zamzami, M Castedo, D Decaudin, SA Susin, ...
The Journal of Immunology 157 (11), 4830-4836, 1996
3021996
PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection
T Hirsch, D Decaudin, SA Susin, P Marchetti, N Larochette, ...
Experimental cell research 241 (2), 426-434, 1998
2971998
Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function
P Marchetti, D Decaudin, A Macho, N Zamzami, T Hirsch, SA Susin, ...
European journal of immunology 27 (1), 289-296, 1997
2731997
Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA
P Marchetti, SA Susin, D Decaudin, S Gamen, M Castedo, T Hirsch, ...
Cancer research 56 (9), 2033-2038, 1996
2511996
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
MS Trabelsi, M Daoudi, J Prawitt, S Ducastel, V Touche, SI Sayin, ...
Nature communications 6 (1), 1-13, 2015
2132015
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437
AS Belzacq, C El Hamel, HLA Vieira, I Cohen, D Haouzi, D Métivier, ...
Oncogene 20 (52), 7579-7587, 2001
2132001
Measurement of the bottom-strange meson mixing phase in the full CDF data set
T Aaltonen, BÁ González, S Amerio, D Amidei, A Anastassov, A Annovi, ...
Physical review letters 109 (17), 171802, 2012
1922012
The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition
N Zamzami, I Marzo, SA Susin, C Brenner, N Larochette, P Marchetti, ...
Oncogene 16 (8), 1055-1063, 1998
1921998
The system can't perform the operation now. Try again later.
Articles 1–20